Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 10Head & Neck 2Gynecologic 2

Conditions

Squamous Cell Carcinoma of Head and Neck 5Breast Neoplasms 4Uterine Cervical Neoplasms 3Ovarian Neoplasms 3Head and Neck Neoplasms 3Endometrial Neoplasms 3Neoplasms by Site 2Neoplasms 2Hereditary Sensory and Autonomic Neuropathies 2Breast Diseases 2Salivary Gland Neoplasms 1Esophageal Squamous Cell Carcinoma 1

Interventions

Fulvestrant 2Alpelisib 2tipifarnib 1ribociclib 1palbociclib 1exemestane 1abemaciclib 1Tamoxifen 1STX-478 1SF 1126 1Panobinostat 1PX-866 1Metformin 1Letrozole 1Imlunestrant 1Everolimus 1Docetaxel 1Cetuximab 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hereditary Sensory and Autonomic Neuropathies × Fulvestrant × Head & Neck × Clear all
NCT05768139 2026-06-04

PIKALO-1

Eli Lilly and Company

Phase 1/2 Recruiting
880 enrolled
BreastGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Neoplasms, Neoplasms by Site, Hereditary Sensory and Autonomic Neuropathies, Ovarian Neoplasms, Endometrial Neoplasms

NCT06993844 2026-05-06

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Ensem Therapeutics

Phase 1/2 Recruiting
233 enrolled
BreastGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Neoplasms, Neoplasms by Site, Hereditary Sensory and Autonomic Neuropathies, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡